Serotype 19A Streptococcus pneumoniae has been classified as having low invasive potential (4, 19, 23) but appears equally capable of causing nasopharyngeal colonization, acute otitis media, and invasive disease (24, 26) . Due to this capability, serotype 19A was one of the most prevalent serotypes, together with the group included in the pneumococcal 7-valent conjugate vaccine (PCV7) prior to the introduction of PCV7, among both colonizing strains (17) and invasive isolates (12, 22) . There has been an increase over time in the prevalence of serotype 19A among invasive and noninvasive Streptococcus pneumoniae isolates, and although the beginning of this increase occurred in some countries prior to PCV7 introduction (6, 8, 12, 15) , in others it occurred after (21, 28) . In addition to the fact that serotype 19A could fill the ecological niche left by the reduction in the number of PCV7 types after vaccine introduction (12, 14, 25) , other facts have been postulated for the multifactorial explanation of the increasing 19A prevalence: (i) the macrolide and penicillin nonsusceptibility prevalence within this serotype that makes it selectable by antibiotic use (12) , (ii) the antibiotic pressure together with capsular switching from a resistant clone (5) , (iii) the emergence (within serotype 19A) of a minor resistant clone existing prior to introduction of PCV7 (16) , (iv) the appearance of new resistant clones (2) , or (v) any of them alone or in combination among the streptococcal population in which secular changes in serotype frequencies occur (6, 12) . For all these reasons it is worthy to explore the evolution over time of antibiotic nonsusceptibility and its relation to clonality, since it may have preventive and therapeutic consequences.
The aim of this study was to analyze the genetic structure (through multilocus sequence typing [MLST]) of all serotype 19A pediatric pneumococcal isolates received at the Spanish Reference Laboratory for Pneumococci (SRLP) from 1990 to 2008 and its relation to antibiotic nonsusceptibility, in order to shed light on the epidemiological changes of serotype 19A in Spain.
MATERIALS AND METHODS
All serotype 19A isolates among the 4,714 pediatric (Ͻ15 years of age) invasive isolates received at the SRLP from January 1990 to December 2008 were considered. Serotyping was performed by the Quellung reaction and/or dot blot assay (13) . Additionally, all 19A isolates were tested for serotype 19A/19F using a previously described method of real-time PCR (27) . MLST was carried out as previously described (10) . Briefly, internal fragments of the aroE, gdh, gki, recP, spi, xpt, and ddl genes were amplified by PCR from chromosomal DNA using the primer pairs described by Enright and Spratt (10) . The amplified fragments were directly sequenced in each direction using the same primers of the initial amplification. The sequences at each of the seven loci were compared with the sequences of all of the known alleles at those loci. Sequences identical to the sequence of a known allele were assigned the same allele number. An allelic profile varying in one of the seven housekeeping genes is referred to as a single-locus variant (SLV). The assignment of alleles at each locus was carried out using the software available at the pneumococcal MLST website (http://www .mlst.net). Phylogenetic analysis of sequence types (STs) was performed using the program eBURST, which uses a model of bacterial evolution to produce clusters of closely related genotypes that are all descended from the founding STs; these clusters are identified as clonal complexes (CCs). STs and CCs were displayed graphically based on relationships to each other via SLVs, with the distance between STs and CCs based on the number of SLVs between them. Allelic combinations not described in the MLST database were submitted and assigned new ST numbers.
MIC determination was performed by agar dilution using Mueller-Hinton agar (Difco Laboratories, Detroit, MI) supplemented with 5% sheep blood (Biomedics, Madrid, Spain) as the culture medium and incubation under a 5% CO 2 atmosphere, as previously described (11) . S. pneumoniae ATCC 6303 and S. pneumoniae ATCC 49619 plus five clinical strains were used as quality controls, as in all determinations in the SRLP (11) . CLSI breakpoints (7) were used for interpretation (susceptibility/resistance [g/ml]): penicillin orally, Յ0.06/Ն2; penicillin parenterally, Յ2/Ն8; amoxicillin, Յ 2/Ն8; cefotaxime (nonmeningitis), Յ1/Ն4; and erythromycin, Յ0.25/Ն1.
Trends along time were explored using the lineal regression command (SPSS V14; SPSS Inc., Chicago, IL), with prevalence percentages plotted as dependent variables and time (year) as an independent variable. A P value of Յ0.05 was considered significant. Of the 514 isolates, 30% had been isolated from children younger than 12 months, 35% from children aged 12 to 24 months, 24.7% from children aged 2 to 5 years, 3.5% from children older than 5 years, and 6.8% from children with ages not specified by the hospitals sending the isolates. A total of 80.0% of isolates were from blood samples, 10.5% from cerebrospinal fluid (CSF) samples, 8.0% from pleural fluid samples, and 1.6% from other types of samples (5 joint fluid, 2 peritoneal fluid, and 1 biopsy sample). Figure 4 shows trends in the nonsusceptibility prevalence among all 19A isolates from the year 2000 on. Global nonsusceptibility rates of the 43 isolates received from 1990 to 1999 (with Յ8 isolates per year) were 32.6% for penicillin, 30.2% for erythromycin, and 0% for cefotaxime. No significant trends were found for erythromycin nonsusceptibility (ranging from 38.5% to 66.7%; R 2 ϭ 0.022; ␤ ϭ 0.548; P ϭ 0.702) and cefotaxime nonsusceptibility (ranging from 0.0% to 7.8%; R 2 ϭ 0.196; ␤ ϭ 0.508; P ϭ 0.232), but significant increasing trends (24, 26) , consequently favoring capsular switching. All these factors have contributed to the genetic diversity of serotype 19A, providing significant survival advantages and making it one of the most prevalent serotypes among invasive isolates nowadays.
RESULTS

A
The most frequent ST found in our study was ST1201 (18.9%), a nonrelated Pneumococcal Molecular Epidemiology Network (PMEN) clone, with no significant trend from 2000 to 2008 and susceptibility to ␤-lactams and macrolides. The second most frequent ST was ST202 (9.9%), a double-locus variant of the Taiwan 19F -14 PMEN clone, with a significant decreasing trend through all the study period and susceptibility to ␤-lactams but not to macrolides (66.7% nonsusceptibility to erythromycin).
All STs showing Ͼ90% penicillin nonsusceptibility (i.e., ST81, ST276, ST320, ST878, ST2013, and ST4461, exhibiting almost 100% nonsusceptibility) showed significant increasing trends in the period 2000 to 2008, except ST276 (96.1% nonsusceptibility; no significant trend) and ST81 (90.9% nonsusceptibility; significant decreasing trend). Among them, the most frequent ST was ST276 (9.9% of total 19A invasive isolates), closely followed by ST878 (8.9% of total), both singlelocus variants of the clonal complex with ST230 as the founder and identifier of the Denmark 14 -32 clone. This clonal complex has also been reported as an increasing cause of pneumococcal infection in Portugal, which shares more than 1,000 km with Spain, and the spread of clones between countries may easily occur (1). ST276 had previously been reported in Spain (2, 18) and the United States (17) , and in France the spread of isolates related to ST276 has been associated with the increase in pediatric invasive pneumococcal disease (IPD) by serotype 19A after PCV7 introduction (16) . In Israel, ST276 has been associated with a 63.1% increase in the incidence of acute otitis media due to serotype 19A in Bedouin children, a population not vaccinated with PCV7 (8) . Of note is closely related ST878, appearing in 2003 in our study. This ST was first detected in 2000 in Sri Lanka with a serotype 23F capsule, but isolates in Germany in 2004 already showed the serotype 19A capsule according to the MLST database (http://www.mlst.net).
Another ST associated with penicillin nonsusceptibility was ST81 (3.9% of total 19A invasive isolates but showing a significant decreasing trend over the current decade), the sadly famous Spain 23F -1-19A clone of great concern in the 1980s. Considering the paradigm of capsular switching between serotypes 19A and 23F but also with the 19F, 14, and 9V serotypes, the significant decreasing trend of ST81 in the current study is in accordance with other studies (3, 9) , showing a turndown in the prevalence of the Spain 23F -1 (ST81) clone, associated with the dramatic decrease of serotype 23F in Spain (12) .
Of great concern is the rapid spread of ST320, a doublelocus variant of the Taiwan 19F -14 PMEN clone showing fully nonsusceptibility to penicillin and erythromycin (with high MIC 90 values) and high rates of nonsusceptibility to amoxicillin (87%) and cefotaxime (43.5%). Although ST320 had previously been reported in Spain (2, 18) , it was first detected in 2007 in the present study, with a significant increase in the last few years. A South Korean study reported the presence of ST320 showing serotype 19A and 19F capsules in the early 1990s (6) . The increase in serotype 19A in children was associated with the spread of ST320 before (1998 to 2003) and after (2004 to 2006) PCV7 introduction in South Korea (6) . However, ST320 has been associated with the increase in multidrug-resistant serotype 19A invasive isolates isolated in the United States after PCV7 introduction (17, 21) .
We also found in the present study the clonal cluster with ST199 as the ST founder belonging to the Netherlands 15B -37 PMEN clone established worldwide, including ST199 (20 isolates), ST876 (8 isolates), ST416 (6 isolates), ST2109 (3 isolates), ST3934 (2 isolates), and ST2471, ST2472, ST4152, ST274, ST2343, and ST856 (one isolate each) in the current decade, most of them penicillin-susceptible isolates, in agreement with previous studies in Spain (18) . In the United States, expansion of serotype 19A occurred through the clonal spread of ST199, which existed prior to universal vaccination (20, 25) (20) .
Globally, the analysis of the genetic structure of serotype 19A in the present study shows three related phenomena: (i) the low prevalence in the present decade of minor penicillinnonsusceptible STs existing in the previous decade as ST81 (ST276 was detected in the year 2000, also prior to PCV7 introduction); (ii) the rapid spread of new penicillin-nonsus- A close look at the MLST database suggests that capsular switching is more frequent than expected, since many STs are shared by several serotypes. In this sense, eight STs (ST81, ST172, ST199, ST276, ST320, ST663, ST2012, and ST2013) express serotypes 19A or 19F, three STs (ST63, ST199, and ST2074) express serotype 19A or serogroup 15, ST93 expresses serotype 21 or 19A, and ST695 expresses serotype 19A or 4. Interestingly, capsular switching and acquisition of antibiotic resistance may occur through a single transformation event, as suggested by the proximity of the 19A-type capsular locus and the flanking pbp1a and pbp2x sequences (17, 29) , linking the ability of pneumococci to exchange DNA to the success of some serotypes in colonizing and sharing the same ecologic niche.
In conclusion, our study warns about the emergence of serotype 19A STs associated with high levels of antibiotic nonsusceptibility and multidrug resistance. The outstanding role of ST320 and ST878 in occupying the niche left by some PCV7-related resistant STs should be highlighted. Because of the previously shown increasing trend of IPD due to serotype 19A (12) and the rapid expansion of STs related to antibiotic resis- 
